Weili Sun

1.9k total citations · 1 hit paper
29 papers, 891 citations indexed

About

Weili Sun is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Weili Sun has authored 29 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Weili Sun's work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Weili Sun is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Weili Sun collaborates with scholars based in United States, China and Sweden. Weili Sun's co-authors include James R. Downing, Sonny Ang, Noel Lenny, Robert B. Lorsbach, Jennifer C. Moore, Hirotsugu Uemura, Sharon McCarthy, Byung Ha Chung, Andrea Juliana Gomes and Anders Bjartell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Weili Sun

29 papers receiving 884 citations

Hit Papers

Apalutamide in Patients With Metastatic Castration-Sensit... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
    2021 285 citations Kim N., Simon Chowdhury et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weili Sun United States 12 296 295 253 197 164 29 891
Kenneth B. DeSantes United States 16 275 0.9× 82 0.3× 322 1.3× 175 0.9× 354 2.2× 32 1.1k
H. J. Illiger Germany 11 386 1.3× 266 0.9× 172 0.7× 154 0.8× 555 3.4× 28 974
Behnaz Parhami-Seren United States 18 348 1.2× 79 0.3× 470 1.9× 129 0.7× 81 0.5× 39 983
Frank J. Godinho United States 7 431 1.5× 135 0.5× 296 1.2× 250 1.3× 193 1.2× 12 849
Mark Cornfeld United States 11 294 1.0× 151 0.5× 127 0.5× 112 0.6× 497 3.0× 33 838
S Bose United States 15 773 2.6× 108 0.4× 67 0.3× 237 1.2× 335 2.0× 26 1.4k
G. Ucci Italy 19 357 1.2× 132 0.4× 463 1.8× 137 0.7× 355 2.2× 61 931
Ernest Marshall United Kingdom 17 287 1.0× 232 0.8× 66 0.3× 82 0.4× 482 2.9× 42 938
Wichai Chinratanalab United States 11 314 1.1× 89 0.3× 413 1.6× 40 0.2× 512 3.1× 48 1.0k
Nicola Calvani Italy 16 325 1.1× 139 0.5× 157 0.6× 132 0.7× 382 2.3× 46 911

Countries citing papers authored by Weili Sun

Since Specialization
Citations

This map shows the geographic impact of Weili Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Sun more than expected).

Fields of papers citing papers by Weili Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Sun. The network helps show where Weili Sun may publish in the future.

Co-authorship network of co-authors of Weili Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Sun. A scholar is included among the top collaborators of Weili Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Sun. Weili Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orgel, Etan, Jiyoon Kim, Gang Li, et al.. (2021). Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial. Blood Advances. 5(7). 1853–1861. 38 indexed citations
2.
N., Kim, Simon Chowdhury, Anders Bjartell, et al.. (2021). Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study. Journal of Clinical Oncology. 39(20). 2294–2303. 285 indexed citations breakdown →
3.
Ohtani, Hitoshi, Andreas Due Ørskov, Linn Gillberg, et al.. (2020). Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine. Cancer Research. 80(12). 2441–2450. 36 indexed citations
4.
Sun, Weili, et al.. (2020). Blastic Plasmacytoid Dendritic Cell Neoplasm in Children. Hematology/Oncology Clinics of North America. 34(3). 601–612. 9 indexed citations
5.
Tian, Kang, et al.. (2020). MiR-28-5p mediates the anti-proliferative and pro-apoptotic effects of curcumin on human diffuse large B-cell lymphoma cells. Journal of International Medical Research. 48(7). 1220743344–1220743344. 8 indexed citations
6.
Abdel‐Azim, Hisham, Weili Sun, & Lingtao Wu. (2019). Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy. Pharmacology & Therapeutics. 204. 107403–107403. 8 indexed citations
7.
Wang, Yuanyu, Weili Sun, Jiankai Yang, et al.. (2019). PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression. Cell Structure and Function. 44(1). 29–39. 15 indexed citations
8.
Sun, Weili, Huaying Liu, Young Kim, et al.. (2018). First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases. Journal of Hematology & Oncology. 11(1). 61–61. 37 indexed citations
9.
Sun, Weili, Kang Tian, Jianping Sun, et al.. (2018). Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410. Bioscience Reports. 39(1). 46 indexed citations
10.
Pawłowska, Anna, Nicole Karras, Jerry C. Cheng, et al.. (2017). HLA-Haploidentical Stem Cell Transplant with Pre-Transplant Immunosuppression for Patients with Sickle Cell Disease. Blood. 130. 5478–5478. 1 indexed citations
11.
Pawłowska, Anna, Jerry C. Cheng, Nicole Karras, et al.. (2017). HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 24(1). 185–189. 35 indexed citations
12.
Li, Lin, Xiaotian Qi, Weili Sun, et al.. (2016). Am80‐ GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia‐associated infection and mortality. EMBO Molecular Medicine. 8(11). 1340–1359. 11 indexed citations
13.
Yeo, Kee Kiat, Paul S. Gaynon, Cecilia Fu, Alan S. Wayne, & Weili Sun. (2016). Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance. Journal of Pediatric Hematology/Oncology. 38(5). 345–349. 5 indexed citations
14.
Sun, Weili, Etan Orgel, Jemily Malvar, et al.. (2016). Treatment‐related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia. Pediatric Blood & Cancer. 63(11). 1943–1948. 20 indexed citations
15.
Sun, Weili, Paul S. Gaynon, Richard Sposto, & Alan S. Wayne. (2015). Improving access to novel agents for childhood leukemia. Cancer. 121(12). 1927–1936. 5 indexed citations
16.
17.
Liu, Yin, Jingyan Tang, Hui-liang Xue, et al.. (2014). High-Resolution Melting Curve Analysis, a Rapid and Affordable Method for Mutation Analysis in Childhood Acute Myeloid Leukemia. Frontiers in Pediatrics. 2. 96–96. 9 indexed citations
18.
19.
20.
Lorsbach, Robert B., Jennifer C. Moore, Sonny Ang, et al.. (2003). Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood. 103(7). 2522–2529. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth B. DeSantes Breakdown of academic impact, for papers by H. J. Illiger Breakdown of academic impact, for papers by Behnaz Parhami-Seren Breakdown of academic impact, for papers by Frank J. Godinho Breakdown of academic impact, for papers by Mark Cornfeld Breakdown of academic impact, for papers by S Bose Breakdown of academic impact, for papers by G. Ucci Breakdown of academic impact, for papers by Ernest Marshall Breakdown of academic impact, for papers by Wichai Chinratanalab Breakdown of academic impact, for papers by Nicola Calvani
Rankless by CCL
2026